Heart failure trial testing nerve treatment for lung pressure
Part of Heart & circulation clinical trials.
This trial tests a new treatment that uses a device to calm overactive nerves in the lung's blood vessels. It is for heart failure patients who also have high blood pressure in their lungs, to see if it can help them breathe easier and feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart's pumping strength is at least 40% (measured in the last 3 months).
- You have high blood pressure in your lungs (mean pressure over 20 mmHg at rest).
- You are on stable heart failure medications and your fluid levels have been well controlled for at least 1 month.
- Your kidneys work well enough (GFR of 25 or higher).
- You can take blood thinners like aspirin or clopidogrel.
- You have no serious leakage in your heart valves or other major lung artery problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
This trial tests a procedure that uses energy to calm overactive nerves in the kidney, which may help improve heart failure symptoms. It is for people with heart failure who are already on the best available medicines but still have symptoms.
This trial tests a nerve block procedure to improve heart function in people with heart failure and reduced pumping ability. It aims to see if blocking certain nerves can help you feel better and be more active.
This trial tests a procedure called pulmonary artery denervation (PADN) for people with heart failure and a certain type of high blood pressure in the lungs (pulmonary hypertension Group 2). The goal is to see if using a special device called the Gradient Denervation System can help control the high pressures and improve your symptoms.
This trial tests a procedure called pulmonary artery denervation (using a catheter to treat nerves in the lung's blood vessels) for people with heart failure who still have a preserved ejection fraction (their heart squeezes normally but doesn't fill properly). The procedure aims to reduce pressure in the lungs and improve symptoms like shortness of breath. Participants must be on stable heart failure medications and have elevated BNP levels, among other requirements.
This study tests a new procedure called pulmonary artery denervation (PADN) to lower high blood pressure in the lungs that persists after a mitral valve repair. It aims to see if this extra treatment improves symptoms and outcomes for people with this condition.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.